Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added revision entry v3.4.3 and removed v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-05T18:52:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    - The record history shows a new revision v3.4.2 added and v3.4.1 removed, indicating a minor update to the page’s revision history. There are no visible changes to study data or page content.
    Difference
    0.1%
    Check dated 2026-02-12T01:53:12.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page history now shows an addition of Revision: v3.4.1 and removal of Revision: v3.4.0, reflecting a minor update to the record’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:35:55.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    UI updates add a Show glossary option, green and red highlights to indicate additions and deletions, and a Revision: v3.4.0, with No FEAR Act data removal noted (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T21:22:31.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the record history. Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:20:41.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:29.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.